Based on historical performance, Abbott Labs (NYSE: ABT) appears to be a better bet compared to Medtronic in the current crisis. The current coronavirus crisis will likely impact medical devices company on two fronts, 1. supply chain disruptions, and 2. decline in number of procedures performed...